Farmas USA

AMRN

http://seekingalpha.com/article/4045161-amarin-secures-enough-cash-2017

ADXS

del viernes noche, S3 250M (50M ATM que va a colocar Cantor)

http://ir.advaxis.com/all-sec-filings/content/0001493152-17-001337/forms-3.htm?TB_iframe=true&height=auto&width=auto&preload=false

INO
Inovio teams up with ApolloBio to develop VGX-3100 in China

Inovio will receive $3M upfront, $12M when the FDA lifts its clinical hold on VGX-3100, up to $20M in regulatory milestones and double-digit royalties on net sales. ApolloBio will be responsible for all clinical development costs in the territory.

Under a separate equity agreement, ApolloBio will make up to a $35M equity investment in Inovio.

http://seekingalpha.com/news/3242746-inovio-teams-apollobio-develop-vgxminus-3100-china?app=1&uprof=44#/email_link

TEVA

Teva Reports Full Year and Fourth Quarter 2016 Financial Results

http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-newsArticle&ID=2245365

Reports Q4 revenue $6.5B consensus $6.25B. Backs FY17 revenue $23.8B-$24.5B, consensus $23.69B

Q4 EPS of $1.38 beats by $0.03.
Revenue of $6.49B (+33.0% Y/Y) beats by $240M.

XOMA

XOMA Announces Pricing of $25 Million Registered Offering of Common Stock and Convertible Preferred a 4,03

XOMA

Capitalización a viernes 24 y algo, offering de 25... No está nada mal esa dilución...

AGN

Mueve pieza

Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion

http://finance.yahoo.com/news/allergan-acquire-zeltiq-best-class-130000562.html

http://www.streetinsider.com/Press+Releases/Zogenix+Announces+Initiation+of+Clinical+Efficacy+Portion+of+Study+1504+for+ZX008+in+Dravet+Syndrome/12532536.html?uid=135551&si_email_click=2017021308